Results 241 to 250 of about 281,370 (287)

Prognostic model for pulmonary metastasis in patients with HER2-positive breast cancer: a population-based study. [PDF]

Breast Cancer
Pang J, Huang B, Yan W, He H, Liao N, Sun W, Li Y, Luo L, Zeng W.   +8 more
europepmc   +1 more source

Prevalence of HER2-low status and outcomes in early-stage HER2-negative breast cancer. [PDF]

NPJ Breast Cancer
Singareeka Raghavendra A, Liu DD, Pasyar S, Damodaran S, Shen Y, Mouabbi JA, Barcenas CH, Tripathy D.   +7 more
europepmc   +1 more source

NeoProspect HER2-low: Response and Prognosis After Neoadjuvant Treatment in Patients with HER2-low Breast Cancer. [PDF]

Cureus
Pratas Guerra L, Sá E Silva R, Simões J, Quinto Pereira M, Gonçalves L, Couto M, Gonçalves MB, Neves S, Martins Braga M, Queirós Coelho J, Sousa MJ, Romão R, Gonçalves F, Araújo A.   +13 more
europepmc   +1 more source

Real-world outcomes of trastuzumab deruxtecan in patients with HER2+ metastatic breast cancer: Turkish oncology group multicenter study. [PDF]

Ther Adv Med Oncol
Sahin TK, Kemik F, Muglu H, Acikgöz Yildiz B, Biter S, Tunbekici S, Oruc A, Guren AK, Kaban K, Guzel HG, Erol C, Aykan MB, Koylu B, Ekinci OB, Deliktas Onur I, Kalem A, Altunok O, Seyyar M, Guney B, Akdogan O, Ismayilov R, Ardic FS, Yazici M, Majidova N, Turker S, Esin E, Cabuk D, Yasar HA, Oguz A, Yazici O, Gursu RU, Yılmaz M, Yesil Cinkir H, Ates O, Celik E, Karadurmus N, Demirci U, Ozturk B, Mandel NM, Bayoglu IV, Araz M, Goker E, Bayram E, Erdem D, Selcukbiricik F, Basaran G, Sezer A, Dogu GG, Kemal Y, Bilici A, Gunduz S, Guven DC, Aksoy S.   +52 more
europepmc   +1 more source